Phase Ia/Ib study of RS-0139, a novel tumor-targeted delivery of docetaxel, in patients with recurrent, locally advanced, or metastatic non-small cell lung cancer (NSCLC)
Phase Ia/Ib study of RS-0139, a novel tumor-targeted delivery of docetaxel, in patients with recurrent, locally advanced, or metastatic non-small cell lung cancer (NSCLC)
thumbnail.default.placeholder
Tarih
2022-01-01
Yazarlar
Orer, H. S.
Nomak, G.
Oksuzoglu, B.
Senturk, R.
Eralp, Y.
Yumuk, F.
Nomak, H.
Sanyal, R.
Süreli Yayın başlığı
Süreli Yayın ISSN
Cilt Başlığı
Yayınevi
Dergi Adı
ANNALS OF ONCOLOGY